Pfizer CEO Says Company Can Deliver 10 Percent More Doses to the U.S. By the End of May Than Previously Agreed

Pfizer CEO Albert Bourla announced Tuesday that the drugmaker has accelerated production of its two-shot COVID-19 vaccine and will be able to deliver 300 million doses to the United States two weeks early, reports CNBC . He said Pfizer can deliver 10 percent more doses to the U.S. by the end of May than it had previously agreed to, for 220 million shots in total rather than 200 million. The announcement came as dozens of states temporarily halted the use of Johnson & Johnson's (J&J) single-dose vaccine, after six women in the U.S. developed a rare blood-clotting disorder. Some states, including New York, said they will use Pfizer's vaccine in place of the J&J shot for appointments that had already been booked.